Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 3,359 | 3,064 | 3,968 | 48 | 5,390 |
| Cost of Goods | 1,587 | 1,318 | 971 | 1,178 | 2,367 |
| Gross Profit | 1,772 | 1,746 | 2,997 | -1,130 | 3,023 |
| Operating Expenses | 8,004 | 8,958 | 8,397 | 9,215 | 8,950 |
| Operating Income | -5,645 | -6,894 | -4,429 | -10,167 | -5,560 |
| Other Income | -102 | 57 | 108 | 290 | 81 |
| Pre-tax Income | -5,747 | -6,837 | -4,321 | -9,877 | -5,479 |
| Net Income Continuous | -5,747 | -6,837 | -4,321 | -9,877 | -5,479 |
| Net Income | $-5,747 | $-6,837 | $-4,321 | $-9,877 | $-5,479 |
| EPS Basic Total Ops | -0.60 | -0.70 | -0.50 | -1.10 | -0.60 |
| EPS Basic Continuous Ops | -0.62 | -0.74 | -0.47 | -1.06 | -0.60 |
| EPS Diluted Total Ops | -0.60 | -0.70 | -0.50 | -1.00 | -0.60 |
| EPS Diluted Continuous Ops | -0.62 | -0.74 | -0.47 | -1.03 | -0.60 |
| EBITDA(a) | $-4,759 | $-6,002 | $-3,503 | $-9,247 | $-4,648 |